NUWE
Get informed when a big investor buys or sells
+ FollowUndervalued by 85.1% based on the discounted cash flow analysis.
| Market cap | $106,953.00 |
|---|---|
| Enterprise Value | $-3,615,047.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-25.39 |
| Beta | 0.3 |
| Outstanding Shares | 181,243 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | 0.02 |
| Price to Book Ratio | -0.08 |
| Enterprise Value to Revenue | -0.4 |
| Enterprise Value to EBIT | 0.46 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.06 |
| Debt to Equity | -0.1 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 14.02%▲ 5.93% |
|---|---|
| Total Invested | $305,343▲ 34.42% |
| Investors Holding | 8▼ 2.00% |
No data
Nuwellis, Inc. , formally CHF Solutions, is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufact...